Cover Image
市場調查報告書

全球疼痛管理療法市場 (各治療法 (抗痙攣藥、抗憂鬱症藥、麻醉劑、NSAID、類鴉片物質)、各適應症):產業分析、規模、佔有率、成長率、趨勢、預測

Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs, Opioids; Indication) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023

出版商 Transparency Market Research 商品編碼 277689
出版日期 內容資訊 英文 130 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球疼痛管理療法市場 (各治療法 (抗痙攣藥、抗憂鬱症藥、麻醉劑、NSAID、類鴉片物質)、各適應症):產業分析、規模、佔有率、成長率、趨勢、預測 Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs, Opioids; Indication) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023
出版日期: 2016年08月01日 內容資訊: 英文 130 Pages
簡介

本報告提供全球疼痛管理療法市場相關調查,主要的推動及阻礙市場要素和今後的市場機會,各治療法 (抗痙攣藥,抗憂鬱症藥,麻醉劑,NSAIDs,類鴉片物質等) 及各適應症的市場趨勢預測,各地區市場、主要國家市場詳細趨勢,主要企業簡介、市場佔有率的資訊彙整,為您概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 全球疼痛管理療法市場:產業分析

  • 市場動態
    • 市場成長的促進要素
    • 市場成長的阻礙要素
    • 市場機會
  • 市場向心力分析
  • 治療藥物別的市場收益額 (今後11年份)
    • 概要
    • 抗痙攣藥
    • 抗憂鬱症藥
    • 麻醉劑
    • NSAIDs (非類固醇消炎劑)
    • 類鴉片物質
    • 抗偏頭痛藥
    • 其他非麻醉劑止痛藥
  • 各適應症的市場收益額 (今後11年份)
    • 概要
    • 神經性疼痛
    • 纖維肌痛
    • 關節痛
    • 慢性腰痛
    • 偏頭痛
    • 手術後疼痛
  • 癌症性疼痛
  • 市場佔有率分析

第4章 北美市場趨勢預測 (以金額為準,今後11年份)

  • 主要趨勢分析
  • 治療藥物別
  • 各適應症

第5章 歐洲市場趨勢預測 (以金額為準,今後11年份)

第6章 亞太地區市場趨勢預測 (以金額為準,今後11年份)

第7章 其他的國家 (RoW)的市場趨勢預測 (以金額為準,今後11年份)

第8章 主要國家市場概況 (以金額為準,今後11年份)

  • 概要
  • 美國
  • 加拿大
  • 英國
  • 德國
  • 中國
  • 日本
  • 巴西
  • 墨西哥

第9章 企業簡介

  • Abbott Laboratories
  • AstraZeneca
  • Depomed, Inc.
  • Endo Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Purdue Pharma L.P.
  • Teva Pharmaceutical Industries Limited

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Title: Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic; Indication - Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine, Post-operative Pain, Cancer Pain) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023.

This report on the pain management therapeutics market studies the current as well as future prospects of the market globally. The pain management therapeutics market report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the general information and data analysis of the global pain management therapeutics market with respect to the leading market segments based on major therapeutics, and geographies.

The global pain management therapeutics market has been studied based on major segments by therapeutics, by indication and their regional as well as national markets. Based on therapeutics, the global market has been segmented into anticonvulsants, antidepressants, anesthetics, non-steroidal anti-inflammatory drugs (NSAIDS), opioids, other non-narcotic analgesic, and antimigraine agents. Further the market has been segmented according to its indication that includes neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain, and cancer pain. The market for these segments has been extensively analyzed based on their effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

The market overview section of the report explores the dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the pain management therapeutics market and could influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition across different geographies. The competitive scenario among different players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their position and expand their shares in the global pain management therapeutics market.

Geographically, the pain management therapeutics market has been segmented into four regions: North America, Europe, Asia Pacific, and Rest of the World(RoW). Each regional pain management therapeutics market has been further categorized into major national markets such as the U.S, Canada, Germany, the U.K., Japan, China, Brazil, and Mexico. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

The recommendations section included in the report would assist existing market players to expand their market shares, and new companies in establishing their presence in the global pain management therapeutics market. The report also profiles key players operating in this market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited.

The global pain management therapeutics market is segmented as follows:

Global Pain Management Therapeutics Market Revenue, by Therapeutics

  • Anticonvulsants
  • Antidepressants
  • Anesthetics
  • Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  • Opioids
    • Oxycodones
    • Hydrocodones
    • Tramadol
    • Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
  • Antimigraine Agents
  • Other Non-narcotic Analgesic

Global Pain Management Therapeutics Market Revenue, by Indication

  • Neuropathic Pain
  • Fibromyalgia
  • Chronic Back Pain
  • Arthritic Pain
  • Migraine
  • Post-operative Pain
  • Cancer Pain

Global Pain Management Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific (APAC)
    • China
    • Japan
  • Rest of the World (RoW)
    • Brazil
    • Mexico

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

  • 2.1. Pain Management Therapeutics Market, 2016-2024: Market Snapshot
  • 2.2. Global Pain Management Therapeutics Market Share, by Geography,2015,2024
  • 2.3. Global Pain Management Therapeutics Market Revenue, By Therapeutics, (US$ Mn), 2015
  • 2.4. Global Pain Management Therapeutics Market Revenue, By Indication, (US$ Mn), 2015

3. Global Pain Management Therapeutics Market - Industry Analysis

  • 3.1. Market Dynamics
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in incidence of chronic pain disorders
      • 3.1.1.2. Rise in geriatric population with high risk of various diseases
      • 3.1.1.3. Growing adoption of pain management therapeutics among end-users
      • 3.1.1.4. Favorable regulatory scenario and health care reforms
    • 3.1.2. Restraints
      • 3.1.2.1. Patent expiry of key drugs and entry of generics
      • 3.1.2.2. Prescription drug abuse
      • 3.1.2.3. Long term pain relief from surgical procedures, alternative therapies, and medical devices
    • 3.1.3. Opportunities
      • 3.1.3.1. Asia Pacific holds immense potential for pain management therapeutics
      • 3.1.3.2. Launch of novel molecule combinations and drug delivery techniques
  • 3.2. Market Attractiveness Analysis
  • 3.3. Global Pain Management Therapeutics Market Revenue, By Therapeutics, (US$ Mn), 2014-2024
    • 3.3.1. Overview
    • 3.3.2. Anticonvulsants
    • 3.3.3. Antidepressants
    • 3.3.4. Anesthetics
    • 3.3.5. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 3.3.6. Opioids
      • 3.3.6.1. Overview
      • 3.3.6.2. Oxycodones
      • 3.3.6.3. Hydrocodones
      • 3.3.6.4. Tramadol
      • 3.3.6.5. Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
    • 3.3.7. Antimigraine Agents
    • 3.3.8. Other Non-narcotic Analgesic
  • 3.4. Global Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
    • 3.4.1. Overview
    • 3.4.2. Neuropathic Pain
    • 3.4.3. Fibromyalgia
    • 3.4.4. Arthritic Pain
    • 3.4.5. Chronic Back Pain
    • 3.4.6. Migraine
    • 3.4.7. Post-operative Pain
    • 3.4.8. Cancer Pain
  • 3.5. Market Share Analysis

4. North America Pain Management Therapeutics Market Revenue, (US$ Mn), 2014-2024

  • 4.1. Key Trend Analysis
  • 4.2. North America Pain Management Therapeutics Market by Therapeutic
  • 4.3. North America Pain Management Therapeutics Market by Indication

5. Europe Pain Management Therapeutics Market Revenue, (US$ Mn), 2014-2024

  • 5.1. Key Trend Analysis
  • 5.2. Europe Pain Management Therapeutics Market by Therapeutic
  • 5.3. Europe Pain Management Therapeutics Market by Indication

6. Asia Pacific Pain Management Therapeutics Market Revenue, (US$ Mn), 2014-2024

  • 6.1. Key Trend Analysis
  • 6.2. Asia Pacific Pain Management Therapeutics Market by Therapeutic
  • 6.3. Asia Pacific Pain Management Therapeutics Market by Indication

7. Rest of World Pain Management Therapeutics Market Revenue, (US$ Mn), 2014-2024

  • 7.1. Key Trend Analysis
  • 7.2. Rest of World Pain Management Therapeutics Market by Therapeutic
  • 7.3. Rest of World Pain Management Therapeutics Market by Indication

8. Country Snippet

  • 8.1. Overview
  • 8.2. U.S. Pain Management Therapeutics Market Revenue, (US$ Mn) 2014-2024
  • 8.3. Canada Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.4. U.K. Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.5. Germany Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.6. China Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.7. Japan Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.8. Brazil Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.9. Mexico Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio
    • 9.1.3. Financial Overview
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. AstraZeneca
    • 9.2.1. Company Overview
    • 9.2.2. Product Portfolio
    • 9.2.3. Financial Overview
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Depomed, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Product Portfolio
    • 9.3.3. Financial Overview
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. Endo Pharmaceuticals, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Product Portfolio
    • 9.4.3. Financial Overview
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. GlaxoSmithKline plc
    • 9.5.1. Company Overview
    • 9.5.2. Product Portfolio
    • 9.5.3. Financial Overview
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Developments
  • 9.6. Johnson & Johnson
    • 9.6.1. Company Overview
    • 9.6.2. Product Portfolio
    • 9.6.3. Financial Overview
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Developments
  • 9.7. Mallinckrodt Pharmaceuticals
    • 9.7.1. Company Overview
    • 9.7.2. Product Portfolio
    • 9.7.3. Financial Overview
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Developments
  • 9.8. Merck & Co., Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Product Portfolio
    • 9.8.3. Financial Overview
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Developments
  • 9.9. Novartis AG
    • 9.9.1. Company Overview
    • 9.9.2. Product Portfolio
    • 9.9.3. Financial Overview
    • 9.9.4. Business Strategy
    • 9.9.5. Recent Developments
  • 9.10. Pfizer, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Product Portfolio
    • 9.10.3. Financial Overview
    • 9.10.4. Business Strategy
    • 9.10.5. Recent Developments
  • 9.11. Purdue Pharma L.P.
    • 9.11.1. Company Overview
    • 9.11.2. Product Portfolio
    • 9.11.3. Financial Overview
    • 9.11.4. Business Strategy
    • 9.11.5. Recent Developments
  • 9.12. Teva Pharmaceutical Industries Limited
    • 9.12.1. Company Overview
    • 9.12.2. Product Portfolio
    • 9.12.3. Financial Overview
    • 9.12.4. Business Strategy
    • 9.12.5. Recent Developments

List of Figures

  • FIG. 1: Market Segmentation
  • FIG. 2: Global Pain Management Therapeutics Market Share, by Geography, 2015
  • FIG. 3: Global Pain Management Therapeutics Market Share, by Geography, 2024
  • FIG. 4: Global Pain Management Therapeutics Market Revenue, By Therapeutics, (US$ Mn), 2015
  • FIG. 5: Global Pain Management Therapeutics Market Revenue, By Indication, (US$ Mn), 2015
  • FIG. 6: Pain Management Therapeutics Market, by Geography, 2015
  • FIG. 7: Global Anticonvulsants Market Revenue, (US$ Mn), 2014-2024
  • FIG. 8: Global Antidepressants Market Revenue, (US$ Mn), 2014-2024
  • FIG. 9: Global Anesthetics Market Revenue, (US$ Mn), 2014-2024
  • FIG. 10: Global Non-steroidal Anti-inflammatory Drugs (NSAIDS) Market Revenue, (US$ Mn) 2014-2024
  • FIG. 11: Global Oxycodones Market Revenue, (US$ Mn), 2014-2024
  • FIG. 12: Global Hydrocodones Market Revenue, (US$ Mn), 2014-2024
  • FIG. 13: Global Tramadol Market Revenue, (US$ Mn) 2014-2024
  • FIG. 14: Global Other Opioids Market Revenue, (US$ Mn), 2014-2024
  • FIG. 15: Global Antimigraine Agents Market Revenue, (US$ Mn), 2014-2024
  • FIG. 16: Global other non-narcotic analgesic Market Revenue, (US$ Mn), 2014-2024
  • FIG. 17: Global Neuropathic Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 18: Global Fibromyalgia Market Revenue, (US$ Mn), 2014-2024
  • FIG. 19: Global Arthritic Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 20: Global Chronic Back Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 21: Global Migraine Market Revenue, (US$ Mn), 2014-2024
  • FIG. 22: Global Post-operative Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 23: Global Cancer Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 24: Market Share by Marketing Status (Branded & Generic Pharmaceuticals), 2015 (%)
  • FIG. 25: Market Share by Key Players: Branded Pharmaceuticals, 2015 (%)
  • FIG. 26: North America Pain Management Therapeutics Market Revenue, by Therapeutic, 2015
  • FIG. 27: North America Pain Management Therapeutics Market Revenue, by Therapeutic, 2024
  • FIG. 28: North America Opioids Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • FIG. 29: North America Pain Management Therapeutics Market Revenue, by Indication, 2015
  • FIG. 30: North America Pain Management Therapeutics Market Revenue, by Indication, 2024
  • FIG. 31: Europe Pain Management Therapeutics Market Revenue, by Therapeutic, 2015
  • FIG. 32: Europe Pain Management Therapeutics Market Revenue, by Therapeutic, 2024
  • FIG. 33: Europe Opioids Market Revenue, by Therapeutics, (US$ Mn) 2014-2024
  • FIG. 34: Europe Pain Management Therapeutics Market Revenue, by Indication, 2015
  • FIG. 35: Europe Pain Management Therapeutics Market Revenue, by Indication, 2024
  • FIG. 36: Asia Pacific Pain Management Therapeutics Market Revenue, by Therapeutic, 2015
  • FIG. 37: Asia Pacific Pain Management Therapeutics Market Revenue, by Therapeutic, 2024
  • FIG. 38: Asia Pacific Opioids Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • FIG. 39: Asia Pacific Pain Management Therapeutics Market Revenue, by Indication, 2015
  • FIG. 40: Asia Pacific Pain Management Therapeutics Market Revenue, by Indication, 2024
  • FIG. 41: Rest of the World Pain Management Therapeutics Market Revenue, by Therapeutic, 2015
  • FIG. 42: Rest of the World Pain Management Therapeutics Market Revenue, by Therapeutic, 2024
  • FIG. 43: Rest of the World Opioids Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • FIG. 44: Rest of the world Pain Management Therapeutics Market Revenue, by Indication, 2015
  • FIG. 45: Rest of the World Pain Management Therapeutics Market Revenue, by Indication, 2024
  • FIG. 46: U.S. Pain Management Therapeutics Market
  • FIG. 47: Canada Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 48: U.K. Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 49: Germany Pain Management Therapeutics Market
  • FIG. 50: China Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 51: Japan Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 52: Brazil Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 53: Financial Details of Abbott Laboratories (US$ Mn), 2013-2015
  • FIG. 54: Financial Details of AstraZeneca (US$ Mn), 2013-2015
  • FIG. 55: Financial Details of Depomed, Inc. (US$ Mn), 2013-2015
  • FIG. 56: Financial Details of Endo Pharmaceuticals, Inc. (US$ Mn), 2013-2015
  • FIG. 57: Financial Details of GlaxoSmithKline plc(US$ Mn), 2013-2015
  • FIG. 58: Financial Details of Johnson & Johnson (US$ Mn), 2013-2015
  • FIG. 59: Financial Details of Mallinckrodt Pharmaceuticals (US$ Mn), 2013-2015
  • FIG. 60: Financial Details of Merck & Co., Inc. (US$ Mn), 2013-2015
  • FIG. 61: Financial Details of Novartis AG (US$ Mn), 2013-2015
  • FIG. 62: Financial Details of Pfizer, Inc. (US$ Mn), 2013-2015
  • FIG. 63: Financial Details of Purdue Pharma L.P. (US$ Mn), 2013-2015
  • FIG. 64: Financial Details of Teva Pharmaceutical Industries Limited (US$ Mn), 2013-2015

List of Tables

  • TABLE 1: Pain Management Therapeutics Market, 2016-2024: Market Snapshot
  • TABLE 2: Global Pain Management Therapeutics Market Analysis, By Therapeutics (US$ Mn), 2014 - 2024
  • TABLE 3: Global Opioids Market Revenue, by Type, (US$ Mn), 2014-2024
  • TABLE 4: Global Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
  • TABLE 5: North America Pain Management Therapeutics Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • TABLE 6: North America Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn) 2014-2024
  • TABLE 7: Europe Pain Management Therapeutics Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • TABLE 8: Europe Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
  • TABLE 9: Asia Pacific Pain Management Therapeutics Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • TABLE 10: Asia Pacific Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
  • TABLE 11: Rest of the World Pain Management Therapeutics Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • TABLE 12: Rest of the World Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
  • TABLE 13: Pain Management Therapeutics Market Revenue, by Country, (US$ Mn), 2014-2024
Back to Top